| HGNC Family | Zinc fingers |
| Name | zinc finger protein 100 |
| Description | Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe collection of studies provided does not directly address ZNF100; rather, they focus on the functions of oxygen‐sensing prolyl hydroxylase domain (PHD) proteins and their regulation of hypoxia‐inducible factor (HIF) activity. In these works, PHD enzymes (notably PHD1–3) are shown to act as key modulators of cellular adaptation to oxygen availability by promoting HIFα hydroxylation and degradation under normoxia, while their inhibition or genetic deletion under hypoxic or stress conditions leads to HIF stabilization and a consequent shift in metabolic programs, angiogenesis, cell survival, and inflammatory responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nExperimental models across diverse tissues—from skeletal muscle and liver to neurons and vascular smooth muscle—demonstrate that modulation of PHD activity reprograms cellular metabolism (e.g. a shift to anaerobic ATP production or enhanced pentose phosphate pathway flux), reduces oxidative stress, and alters inflammatory gene expression. Such changes underlie protective adaptations against ischemia, reperfusion injury, and other stress-related pathologies. In parallel, PHD inhibition is shown to impact angiogenic responses and even influence erythropoietin production, with implications for conditions such as colitis, myocardial ischemia/reperfusion injury, renal fibrosis, and pulmonary arterial hypertension."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional investigations highlight that interfering with PHD function can alter not only metabolic and vascular responses but also the regulation of pro‐ and anti‐apoptotic pathways, potentially via modulation of transcription factors such as nuclear factor–κB, p53, and ATF4. These findings underscore the therapeutic potential of targeting the oxygen‐sensing machinery to limit tissue injury and pathological remodeling in settings ranging from traumatic brain and spinal cord injury to metabolic and inflammatory diseases, as well as cancer."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOther reports extend these insights by revealing roles for PHD enzymes in governing cell differentiation (for example, in adipogenesis and chondrocyte maturation), in regulating the ubiquitin–proteasome degradation of key signaling proteins, and in controlling vascular tone and remodeling in pulmonary arterial hypertension. Although none of the abstracts directly mention or characterize ZNF100, the broad regulatory networks described—mediated by oxygen-sensing enzymes and their downstream transcriptional cascades—raise the possibility that zinc finger proteins such as ZNF100 might intersect with these pathways, perhaps as transcriptional modulators or as part of feedback regulatory loops."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "S P Terkhorn, J Bohensky, I M Shapiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of HIF prolyl hydroxylase isozymes in growth plate chondrocytes: relationship between maturation and apoptotic sensitivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.20873"}], "href": "https://doi.org/10.1002/jcp.20873"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17044072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17044072"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kotaro Takeda, Hector L Aguila, Nehal S Parikh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-09-114561"}], "href": "https://doi.org/10.1182/blood-2007-09-114561"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18056838"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18056838"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Julián Aragonés, Martin Schneider, Katie Van Geyte, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2007.62"}], "href": "https://doi.org/10.1038/ng.2007.62"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18176562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18176562"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Olga Mikhaylova, Monika L Ignacak, Teresa J Barankiewicz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01231-07"}], "href": "https://doi.org/10.1128/MCB.01231-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18285459"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18285459"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Amandine Ginouvès, Karine Ilc, Nuria Macías, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHDs overactivation during chronic hypoxia \"desensitizes\" HIFalpha and protects cells from necrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0705680105"}], "href": "https://doi.org/10.1073/pnas.0705680105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18347341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18347341"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xing Shen, Chao Wan, Girish Ramaswamy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jor.20886"}], "href": "https://doi.org/10.1002/jor.20886"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19338032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19338032"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Martin Schneider, Katie Van Geyte, Peter Fraisl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2009.09.057"}], "href": "https://doi.org/10.1053/j.gastro.2009.09.057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19818783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19818783"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Murtaza M Tambuwala, Eoin P Cummins, Colin R Lenihan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2010.06.068"}], "href": "https://doi.org/10.1053/j.gastro.2010.06.068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20600011"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20600011"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ram Sudheer Adluri, Mahesh Thirunavukkarasu, Nageswara Rao Dunna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Antioxid Redox Signal (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/ars.2010.3769"}], "href": "https://doi.org/10.1089/ars.2010.3769"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21083501"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21083501"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "William Querbes, Roman L Bogorad, Javid Moslehi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Treatment of erythropoietin deficiency in mice with systemically administered siRNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2012-04-423715"}], "href": "https://doi.org/10.1182/blood-2012-04-423715"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22611156"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22611156"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ruo-Li Chen, Simon Nagel, Michalis Papadakis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2012.232884"}], "href": "https://doi.org/10.1113/jphysiol.2012.232884"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22615432"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22615432"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jie Pan, Herman Yeger, Peter Ratcliffe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hyperplasia of pulmonary neuroepithelial bodies (NEB) in lungs of prolyl hydroxylase -1(PHD-1) deficient mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adv Exp Med Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/978-94-007-4584-1_21"}], "href": "https://doi.org/10.1007/978-94-007-4584-1_21"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23080156"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23080156"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Juyoung Kim, Hyun Jeong Kwak, Ji-Young Cha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of prolyl hydroxylase domain protein (PHD) during rosiglitazone-induced adipocyte differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.493650"}], "href": "https://doi.org/10.1074/jbc.M113.493650"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24338020"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24338020"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Muhammad T Rishi, Vaithinathan Selvaraju, Mahesh Thirunavukkarasu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Microvasc Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mvr.2014.10.009"}], "href": "https://doi.org/10.1016/j.mvr.2014.10.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25446011"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25446011"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Annelies Quaegebeur, Inmaculada Segura, Roberta Schmieder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2015.12.007"}], "href": "https://doi.org/10.1016/j.cmet.2015.12.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26774962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26774962"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Susan F Fitzpatrick, Zsolt Fábián, Bettina Schaible, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2016.04.085"}], "href": "https://doi.org/10.1016/j.bbrc.2016.04.085"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27130823"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27130823"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "S Neitemeier, A M Dolga, B Honrath, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2016.107"}], "href": "https://doi.org/10.1038/cddis.2016.107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27148687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27148687"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Ke Zhu, Pingping Song, Yumei Lai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prolyl hydroxylase domain proteins regulate bone mass through their expression in osteoblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2016.09.011"}], "href": "https://doi.org/10.1016/j.gene.2016.09.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27614241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27614241"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sophie Van Welden, Martine De Vos, Ben Wielockx, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.4861"}], "href": "https://doi.org/10.1002/path.4861"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27981571"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27981571"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Mamoru Takada, Ming Zhuang, Hiroyuki Inuzuka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.14290"}], "href": "https://doi.org/10.18632/oncotarget.14290"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28036276"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28036276"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Karim Ullah, Ann-Helen Rosendahl, Valerio Izzi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-17376-0"}], "href": "https://doi.org/10.1038/s41598-017-17376-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29222481"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29222481"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ezinne Ozurumba, Omana Mathew, Katsuri Ranganna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of hypoxia inducible factor/prolyl hydroxylase binding domain proteins 1 by PPARα and high salt diet."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Basic Clin Physiol Pharmacol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/jbcpp-2017-0074"}], "href": "https://doi.org/10.1515/jbcpp-2017-0074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29500923"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29500923"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Gommaar D'Hulst, Inés Soro-Arnaiz, Evi Masschelein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-13889-6"}], "href": "https://doi.org/10.1038/s41467-019-13889-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31924757"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31924757"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yongzhen Zhao, Heng Zeng, Bo Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Renal Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajprenal.00032.2020"}], "href": "https://doi.org/10.1152/ajprenal.00032.2020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32715763"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32715763"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "George Z Wei, Sujata Saraswat Ohri, Nicolas K Khattar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-inducible factor prolyl hydroxylase domain (PHD) inhibition after contusive spinal cord injury does not improve locomotor recovery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0249591"}], "href": "https://doi.org/10.1371/journal.pone.0249591"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33819286"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33819286"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Elizabeth A Barnes, Reiji Ito, Xibing Che, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents Hypoxia-Induced pulmonary hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Lung Cell Mol Physiol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajplung.00428.2022"}], "href": "https://doi.org/10.1152/ajplung.00428.2022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37847687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37847687"}]}]}]}
|
| Proteins | ZN100_HUMAN |
| NCBI Gene ID | 163227 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ZNF100 has 3,364 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 81 datasets.
Click the + buttons to view associations for ZNF100 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by ZNF100 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of ZNF100 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZNF100 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of ZNF100 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of ZNF100 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of ZNF100 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZNF100 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of ZNF100 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ZNF100 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of ZNF100 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of ZNF100 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of ZNF100 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing ZNF100 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with ZNF100 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZNF100 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with ZNF100 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of ZNF100 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by ZNF100 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with ZNF100 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with ZNF100 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ZNF100 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ZNF100 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of ZNF100 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing ZNF100 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ZNF100 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of ZNF100 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of ZNF100 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of ZNF100 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of ZNF100 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving ZNF100 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving ZNF100 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving ZNF100 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing ZNF100 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by ZNF100 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by ZNF100 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by ZNF100 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL | SNPs regulating expression of ZNF100 gene from the GTEx eQTL dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of ZNF100 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of ZNF100 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZNF100 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of ZNF100 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with ZNF100 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with ZNF100 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with ZNF100 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of ZNF100 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of ZNF100 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of ZNF100 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of ZNF100 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZNF100 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for ZNF100 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of ZNF100 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of ZNF100 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZNF100 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of ZNF100 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of ZNF100 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain ZNF100 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting ZNF100 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of ZNF100 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing ZNF100 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for ZNF100 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ZNF100 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving ZNF100 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving ZNF100 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving ZNF100 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving ZNF100 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of ZNF100 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of ZNF100 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of ZNF100 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of ZNF100 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ZNF100 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of ZNF100 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of ZNF100 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of ZNF100 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of ZNF100 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of ZNF100 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of ZNF100 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of ZNF100 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ZNF100 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of ZNF100 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ZNF100 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with ZNF100 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |